NZX/ASX Announcement
25 November 2024.
TruScreen launches 5-year Cervical Cancer Screening Program in Vietnam, with Ho Chi Minh City Public Health Association (HPHA)
Highlights
• Tripartite Memorandum of Understanding (MOU) signed by TruScreen, Ho Chi Minh City Public Health Association and distributor Gorton Health Services (GHS)
• Program to commence in Q1 CY2025
• 5-year program to screen 260,000 women in Ho Chi Minh City
TruScreen Group Limited (NZX/ASX:TRU) is pleased to announce that it has signed an MOU with the Ho Chi Minh City Public Health Association and Gorton Health Services to implement and conduct a public cervical cancer screening program in Ho Chi Minh City, which has an estimated population of 13 million people.
TruScreen was selected by HPHA for its unique real time, non-invasive, objective cervical cancer screening technology, requiring no pathology infrastructure, that suits the screening program. The portability, ease of use and analytical algorithms real time results align with the programs objective for early detection in large populations.
The program, titled “Community-based Proactive Cervical Cancer Screening Program” will implement a proactive screening model where the program team contact women directly to encourage them to attend screening, and to raise the awareness of the high mortality risk from cervical cancer.
The program will screen patients in existing District Health Centres and Community Health Clinics and may extend to mobile screening. The program will also support and monitor patients with positive test results to attend follow up treatment, and to continue screening throughout their lives.
HPHA was established in 2007 by the Peoples Committee of Ho Chi Minh City and is charged with communication and education on community health management as well as organising and implementing programs, projects and community health events in Ho Chi Minh City.
Marty Dillon, CEO said: “The signing of this MOU further reinforces our TruScreen non-invasive and real time screening as a technology particularly suited for use in low-and-middle income countries. We are increasingly recognised by key government agencies of the ability for TruScreen to be rolled out quickly and economically in large population-based screening programs.”
This announcement was approved for release by the Board.
-ENDS-
For more information, visit www.truscreen.com or contact:
Marty Dillion
Chief Executive Officer
[email protected]
Guy Robertson
Chief Financial Officer
[email protected]